Université Lille 2 Droit et Santé
- Country
- France
- Type
- Beneficiary
- Website
- www.univ-lille2.fr
- Grants received
- 14
Funding record
- 14 grants on record
- €5,629,988.79 awarded in total
- 2008–2014 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
4 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- ACADEMISCH ZIEKENHUIS LEIDEN
- CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
- GOETEBORGS UNIVERSITET
- HELSINGIN YLIOPISTO
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
Calls from this organisation
No published calls from this organisation.
Grants received
- Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology
- Universal Flu Vaccine
- Improving medical treatment adherence : taking into account patients' perception of uncertainty in the causal relationship between their adherence behaviour and their health condition
- Genetics and epigenetics of Type 2 Diabetes physiology
- Value Analysis of Local Utilities of Enterprises from Social sector
- CIVIL SOCIETY ORGANISATIONS IN DESIGNING RESEARCH GOVERNANCE
- COntinuous Multi-parametric and Multi-layered analysis Of DIabetes TYpe 1 & 2
- Chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population
- Understanding food-gut-brain mechanisms across the lifespan in the regulation of hunger and satiety for health
- Fungi in the setting of inflammation, allergy and autoimmune diseases:Translating basic science into clinical practices
- Beta Cell Therapy in Diabetes
- Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical development
- PATIENT SAFETY THROUGH INTELLIGENT PROCEDURES IN MEDICATION
- Memory loss in Alzheimer disease: underlying mechanisms and therapeutic targets
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.